IPP Bureau
Parexel bags Global Customer Value Leadership Award
By IPP Bureau - October 20, 2022
The award recognizes Parexel for delivering the best decentralized trial experience for customers through its capabilities, expertise, and patient recruitment and retention strategies
Health Minister Mandaviya inaugurates CGHS Wellness Centres
By IPP Bureau - October 20, 2022
CGHS would give robust coverage to pensioners and with new innovations and practices
MedScapeIndia launches a poster of 'Girl Child Anthem'
By IPP Bureau - October 20, 2022
The girl child anthem will portray a celebration of a girl child.
Syngene Q2 FY23 PAT up 11% to Rs. 102 Cr
By IPP Bureau - October 20, 2022
Revenue from operations up 26% to Rs. 768 crores
USFDA visit to Alembic Pharmaceuticals Panelav facility
By IPP Bureau - October 19, 2022
None of the observations are related to data integrity and Alembic Pharmaceuticals management believes that they are addressable
NHA join hands with NABH to expedite implementation of ABDM
By IPP Bureau - October 19, 2022
NABH shall encourage and provide assistance in onboarding their accredited/certified facilities on ABDM’s Health Facility Registry
Mandaviya directs officials to focus on strengthening genome sequencing for early detection of variants
By IPP Bureau - October 19, 2022
He also highlighted the need for community awareness for continued implementation of the Covid Appropriate Behaviour (CAB) especially in view of the upcoming festival season
AIIA organises multi-cultural dance competition for Ayurveda Day 2022
By IPP Bureau - October 19, 2022
Inceptua Early Access and Sentynl Therapeutics launch early access program for Nulibry for pediatric patients
By IPP Bureau - October 19, 2022
MoCD Type A is a rapidly progressive autosomal recessive inborn error of metabolism resulting in toxic sulfite levels causing neurologic sequelae
Merck and the Bill & Melinda Gates Medical Research Institute announce licensing agreement for tuberculosis antibiotic candidates
By IPP Bureau - October 19, 2022
The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
Bhushan Akshikar appointed MD of GlaxoSmithKline Pharmaceuticals
By IPP Bureau - October 18, 2022
He is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry
Zydus receives tentative approval from USFDA for Roflumilast tablets
By IPP Bureau - October 18, 2022
Roflumilast Tablets had annual sales of US $248 million in the United States according to IQVIA data
Ajanta Pharma bags India’s "Best Managed Companies" award
By IPP Bureau - October 18, 2022
For the last ten financial years, the company has posted healthy performance with its revenue from operations growing at 15% CAGR and net profit at 23% CAGR
Zydus receives tentative approval from USFDA for Valbenazine capsules
By IPP Bureau - October 18, 2022
Valbenazine Capsules had annual sales of US $781 million in the United States according to IQVIA data
Aster Pharmacy enters KSA in partnership with Al Hokair Holding Group
By IPP Bureau - October 18, 2022
Both the partners will work towards bringing Aster Pharmacy’s in-house quality care products to serve the healthcare needs of the local population in KSA
